Trade Vir Biotechnology ^VIR

Vir Biotechnology stock jumps 22% after hepatitis delta Phase 3 trial success

VIR Stock Soars Over 10% Overnight, Eyes Best Year Ever - Hepatitis Win Sparks Buyout Buzz And Bigger Bullish Bets

Vir Biotechnology Announces Expanded Phase 2 SOLSTICE Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta, Showing Deep and Sustained Viral Suppression, and Exploratory Finite Treatment Data | Morningstar

Vir Biotechnology Announces Primary Endpoint Met in Pivotal Phase 3 ECLIPSE 1 Trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta | Morningstar

Vir Biotechnology (NASDAQ:VIR) Upgraded to Buy at Wall Street Zen - Daily Political

Vir Biotechnology Stock Gets Focus As Phase 3 Hepatitis Delta Data Head To AASLD

Vir Biotechnology (NASDAQ:VIR) Shares Cross Above 50 Day Moving Average - Should You Sell?

Vir Biotechnology (NASDAQ:VIR) Upgraded at Wall Street Zen

Vir Biotechnology (NASDAQ:VIR) Hits New 52-Week High on Analyst Upgrade

Vir Biotechnology (NASDAQ:VIR) Sets New 12-Month High Following Analyst Upgrade - Zolmax

Vir Biotechnology (NASDAQ:VIR) Raised to "Hold" at Zacks Research - Zolmax

Vir Biotechnology (NASDAQ:VIR) Stock Rating Upgraded by Zacks Research

Needham & Company LLC Issues Positive Forecast for Vir Biotechnology (NASDAQ:VIR) Stock Price

Vir Biotechnology Inc (VIR) (Q3 2026) Earnings Call Highlights: Hepatitis Delta Data on Deck ...

Narrower Losses Could Be A Game Changer For Vir Biotechnology (VIR)

What Vir Biotechnology (VIR) Said on Its Q3 Earnings Call - Daily Political

Vir Biotechnology (NASDAQ:VIR) Releases Quarterly Earnings Results, Beats Expectations By $0.18 EPS

Insider Selling: Vir Biotechnology (NASDAQ:VIR) EVP Sells $15,216.19 in Stock

Vir Biotechnology (NASDAQ:VIR) EVP Sells $26,717.70 in Stock - Stock Observer

Vir Biotechnology (NASDAQ:VIR) Stock: Insider Verneuil Vanina De Sells 1,343 Shares - Daily Political

Head-To-Head Review: Vir Biotechnology (NASDAQ:VIR) & BioCryst Pharmaceuticals (NASDAQ:BCRX) - Daily Political

Vir Biotechnology (NASDAQ:VIR) Reaches New 52-Week High - Should You Buy?

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - What's Next?

Gilead Cancer Deal Could Be A Game Changer For Vir Biotechnology (VIR)

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down - Here's What Happened - Stock Observer

Vir Biotechnology (VIR) Projected to Post Quarterly Earnings on Wednesday

Vir Biotechnology (NASDAQ:VIR) Shares Cross Above 50-Day Moving Average - What's Next?

Is Vir Biotechnology (VIR) Undervalued On Its Gilead Oncology Deal?

Comparing Vir Biotechnology (NASDAQ:VIR) and REGENXBIO (NASDAQ:RGNX) - Markets Daily

Vir Biotechnology, Inc. (VIR) - What Are Investment Firms Thinking About This Stock?

Hepatitis B Virus (HBV) Infection Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Ascletis Pharma, Shanghai HEP Pharma, Romark Lab, GSK | ABNewswire

Vir Biotechnology (NASDAQ:VIR) & REGENXBIO (NASDAQ:RGNX) Head-To-Head Survey - Stock Observer

Did Cancer Drug Partnership Just Shift Gilead's (GILD) Investment Narrative? - Simply Wall St News

Could Vir Biotechnology (VIR) Be Above Fair Value After Recent Pipeline News?

I'm Taking Out Some 'Insurance' on My Portfolio With These 2 Stocks

What Could Gilead Sciences (GILD) New Solid Tumor Partnership Mean For Oncology?

Gilead Sciences, Inc. $GILD Stake Trimmed by Curated Wealth Partners LLC - Zolmax

Vir Biotechnology and Gilead Sciences Forge $1.88 Billion Collaboration for Solid Tumor Cancer Therapies, ETPharma

Vir partners with Gilead in $1.8B+ deal for T-cell engagers

Verastem focuses on KRAS G12D therapy, reports 41% ORR in PDAC

Vir Biotechnology Partners With Gilead On Next-Generation Cancer Immunotherapy Programs

Vir Biotechnology Shares Jump on Gilead Cancer Collaboration | Morningstar

Vir CEO sees 'opportunity to do more deals' after striking $1.9B Gilead pact for dual-masked TCEs

Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - What's Next? - Daily Political

Is FDA Fast Track Status Altering The Investment Case For Vir Biotechnology (VIR)?

Is Vir Biotechnology (VIR) Cheap On Fast Track News And SOLSTICE Data Hopes?

Micron Stock Price Forecast 2026–2030: Can AI Memory Demand Reverse a 26% Week-to-Date Sell-Off?

Will Gold Hit $5,000 Again Before the End of 2026?

Arm Holdings Stock Forecast 2026–2030: Can Data-Center Royalty Growth Drive a Recovery?

Is Gold Still a Safe Haven? What Traders Should Know

Boeing Stock Forecast 2026–2030: Can a Record $745 Billion Backlog Reverse BA’s 11% Earnings Sell-Off?

Gold Price Forecast UAE 2026–2030: What Could 24K Gold Cost per Gram?

Is Oracle a Good Buy Right Now? Growth, Valuation and Long-Term Risks

Best Stock CFD Broker in 2026: 9 Platforms Compared

Is SpaceX a Good Stock to Buy in 2026?

Best Gold Stock to Buy Now: 6 Gold Stocks to Watch in 2026

US Stocks Rebound as S&P 500 Gains 2.35% and VIX Drops Below 20

Gold Price Today: XAU/USD Slips Near $4,130 Ahead of US Inflation Data

Nvidia Stock Falls 4.3% as Board Opens Investigation Into CEO Jensen Huang

Anthropic Launches Claude Fable 5.2 and Mythos 5.2 as IPO Scrutiny Intensifies

Gold Price Today: XAU/USD Rises Above $4,100 Ahead of US Inflation Data

Nvidia Board Opens Huang Investigation as AI Financing Risks Draw Scrutiny

Solana Price Near $86 as Support Break Raises Risk of Further Losses

Gold Price Forecast This Week: Can XAU/USD Hold $4,000 Before US CPI?